Literature DB >> 2827373

Nucleotide and deduced amino acid sequence of hemagglutinin-neuraminidase genes of human type 3 parainfluenza viruses isolated from 1957 to 1983.

K L van Wyke Coelingh1, C C Winter, B R Murphy.   

Abstract

We have sequenced the coding and noncoding regions of the hemagglutinin-neuraminidase (HN) genes of six clinical strains of human type 3 parainfluenza virus (PIV3) isolated between 1973 and 1983, and compared them to the prototype 1957 strain. Sequence variability does not result from the accumulation of mutations over time, but represents genetic heterogeneity in HN genes within the PIV3 population. Most of the nucleotide diversity occurs in the 5' noncoding sequences, exclusive of regions supplying transcriptional and translational control elements. Although the overall amino acid homology among HN proteins is very high, most variability is concentrated in domains at the carboxyl and amino terminus. This uneven distribution of amino acid diversity may reflect both functional and structural constraints on different HN domains and the epidemiologic features of PIV3 infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2827373     DOI: 10.1016/0042-6822(88)90402-3

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  Identification of amino acids recognized by syncytium-inhibiting and neutralizing monoclonal antibodies to the human parainfluenza type 3 virus fusion protein.

Authors:  K V Coelingh; E L Tierney
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

2.  Antigenic and functional organization of human parainfluenza virus type 3 fusion glycoprotein.

Authors:  K van Wyke Coelingh; E L Tierney
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

3.  Naturally occurring human parainfluenza type 3 viruses exhibit divergence in amino acid sequence of their fusion protein neutralization epitopes and cleavage sites.

Authors:  K V Coelingh; C C Winter
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

4.  Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase.

Authors:  P M Colman; P A Hoyne; M C Lawrence
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

5.  Isolation and characterization of a naturally occurring parainfluenza 3 virus variant.

Authors:  E M Swierkosz; D D Erdman; T Bonnot; C Schneiderheinze; J L Waner
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

6.  The cDNA-derived investigational human parainfluenza virus type 3 vaccine rcp45 is well tolerated, infectious, and immunogenic in infants and young children.

Authors:  Ruth A Karron; Roberta Casey; Bhagvanji Thumar; Sonja Surman; Brian R Murphy; Peter L Collins; Alexander C Schmidt
Journal:  Pediatr Infect Dis J       Date:  2011-10       Impact factor: 2.129

7.  Evolution of subgroup A respiratory syncytial virus: evidence for progressive accumulation of amino acid changes in the attachment protein.

Authors:  P A Cane; C R Pringle
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  A field isolate of Sendai virus: its high virulence to mice and genetic divergence form prototype strains.

Authors:  T Sakaguchi; K Kiyotani; M Sakaki; Y Fujii; T Yoshida
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

9.  Identification of a new mumps virus lineage by nucleotide sequence analysis of the SH gene of ten different strains.

Authors:  R P Yeo; M A Afzal; T Forsey; B K Rima
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Rapid detection of parainfluenza virus type 3 RNA in respiratory specimens: use of reverse transcription-PCR-enzyme immunoassay.

Authors:  R A Karron; J L Froehlich; L Bobo; R B Belshe; R H Yolken
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.